Thermage, Inc.

The Food & Drug Administration Clears Indication for Thermage Thermacool System

Published in Medical Letter on the CDC and FDA, July 8th, 2007

Thermage(R), Inc. (NASDAQ:THRM) announced that the Food & Drug Administration (FDA) provided a first-time-ever 510 (k) clearance for the non-invasive treatment of periorbital wrinkles and rhytids, including upper and lower eyelids. Thermage's proprietary ThermaCool(R) system, utilizing customized ThermaTip(TM) treatment tips, is the only medical device in the non-invasive skin tightening category with this clearance.

"Thermage is the first and only company to receive FDA clearance for non-invasive eyelid treatments," said Stephen J. Fanning, president and chief executive officer at Thermage. "We believe that the clinical data supporting this milestone further defines...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-07-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry